Agresta Samuel

CIK 0001748961

Chief Medical OfficerDirector

Filings

Latest Apr 3, 2026

Issuers covered

Showing

8 of 8

Page 1

Track record

1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	1	100%	+27.7%	+27.7%	+27.7%	+27.7%
90 days	1	100%	+56.0%	+56.0%	+56.0%	+56.0%
180 days	1	100%	+30.8%	+30.8%	+30.8%	+30.8%
365 days	1	100%	+31.1%	+31.1%	+31.1%	+31.1%

Companies where Agresta Samuel has filed

Ticker	Issuer	Filings	Last filed
FHTX	Foghorn Therapeutics Inc.	4	Sep 13, 2023
RPHM	Reneo Pharmaceuticals, Inc.	3	Apr 3, 2026
INFI	Infinity Pharmaceuticals, Inc.	1	Jun 16, 2022

8 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Apr 3, 2026	RPHMReneo Pharmaceuticals, Inc.	Holdings only	-	-	-
Jan 29, 2025	RPHMReneo Pharmaceuticals, Inc.	Holdings only	-	-	-
Oct 8, 2024	RPHMReneo Pharmaceuticals, Inc.	Holdings only	-	-	-
Sep 13, 2023	FHTXFoghorn Therapeutics Inc.	Holdings only	-	-	-
Aug 18, 2023	FHTXFoghorn Therapeutics Inc.	SSale	311,297	$8.25	$2,568,200
Jan 30, 2023	FHTXFoghorn Therapeutics Inc.	Holdings only	-	-	-
Jun 16, 2022	INFIInfinity Pharmaceuticals, Inc.	Holdings only	-	-	-
Jan 28, 2022	FHTXFoghorn Therapeutics Inc.	Holdings only	-	-	-

Showing 1-8 of 8

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.